Evidence map›Paper›PMID 31236692›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2020

Transvascular transcatheter aortic valve implantation in 2017.

Luise Gaede, Johannes Blumenstein, Christoph Liebetrau, Oliver Dörr, Won-Keun Kim, Holger Nef, Oliver Husser, Jan Gülker, Albrecht Elsässer, Christian W Hamm and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Transcatheter-based aortic valve replacement vs. isolated surgical aortic valve replacement in 2020.Clinical research in cardiology : official journal of the German Cardiac Society · 2022
    Article
  7. Article
  8. Machine learning-based risk prediction of intrahospital clinical outcomes in patients undergoing TAVI.Clinical research in cardiology : official journal of the German Cardiac Society · 2021
    Article
  9. Metabolomic profiling of patients with high gradient aortic stenosis undergoing transcatheter aortic valve replacement.Clinical research in cardiology : official journal of the German Cardiac Society · 2021
    Article
  10. Aortic valve replacement in Germany in 2019.Clinical research in cardiology : official journal of the German Cardiac Society · 2021
    Article
  11. Predictors for low TAVI-prosthesis position assessed by fusion imaging of pre- and post-procedural CT angiography.Clinical research in cardiology : official journal of the German Cardiac Society · 2021
    Article
  12. Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Article
  13. Lower mortality in an all-comers aortic stenosis population treated with TAVI in comparison to SAVR.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Article
  14. Periprocedural embolisation of a Sapien 3 TAVI prosthesis: failure and success.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Luise GaedeDepartment of Internal Medicine I, St. Johannes-Hospital Dortmund, Johannesstrasse 9-13, 44137, Dortmund, Germany.
Johannes BlumensteinDepartment of Internal Medicine I, St. Johannes-Hospital Dortmund, Johannesstrasse 9-13, 44137, Dortmund, Germany.
Christoph LiebetrauDepartment of Cardiology, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.
Oliver DörrMedical Clinic I, Department of Cardiology and Angiology, University of Giessen, Giessen, Germany.
Won-Keun KimDepartment of Cardiology, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.
Holger NefDepartment of Cardiology, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.
Oliver HusserDepartment of Internal Medicine I, St. Johannes-Hospital Dortmund, Johannesstrasse 9-13, 44137, Dortmund, Germany.
Jan GülkerDepartment of Internal Medicine I, St. Johannes-Hospital Dortmund, Johannesstrasse 9-13, 44137, Dortmund, Germany.
Albrecht ElsässerDepartment of Cardiology, Klinikum Oldenburg, Oldenburg, Germany.
Christian W HammDepartment of Cardiology, Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany.
Stephan AchenbachMedizinische Klinik 2, Friedrich Alexander Universität Erlangen-Nürnberg, Erlangen, Germany.
Helge MöllmannDepartment of Internal Medicine I, St. Johannes-Hospital Dortmund, Johannesstrasse 9-13, 44137, Dortmund, Germany. moellmann@me.com.ORCID http://orcid.org/0000-0002-6047-0990

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTranscatheter aortic valve implantation (TAVI) is emerging as the standard of care for patients with severe aortic stenosis. Recent results have been favourable even for patients with low periprocedural risk.

methodsWe analysed the number of procedures, complications, and in-hospital mortality rates of all patients undergoing isolated aortic valve replacement in 2017 in Germany, focussing especially on transvascular (TV) TAVI. Patients were stratified according the German Aortic Valve Score (AKL) into the risk classes low, intermediate, high and very high (≥ 10%).

resultsA total of 17,956 TV-TAVI and 9011 isolated surgical aortic valve replacements (iSAVR) were performed in Germany in 2017. Although the total rate of intraprocedural complications after TV-TAVI was the same as in 2016 (both 7.4%), fewer patients experienced an arterial vascular complication in 2017 (2017: 6.0%; 2016: 7.1%; p < 0.001). Likewise, the rate of new pacemaker implantation decreased (2017: 9.6%; 2016:11.4%; p < 0.001). In-hospital mortality after TV-TAVI and iSAVR was equal (2.7%) in 2017, despite the much higher risk profile of TV-TAVI patients. Using the AKL score as reference, TV-TAVI showed a more favourable observed-to-expected mortality (O/E) ratio (0.89) than iSAVR (1.14)- even more pronounced in patients at low risk (0.81 vs. 1.14).

conclusionsThe rates of major complications like bleeding and permanent pacemaker implantation after TV-TAVI keep declining. In 2017 patients undergoing TV-TAVI had a low in-hospital mortality rate with an O/E ratio < 1, indicating that the results were again better than those of all TAVI and SAVR of the previous year. Overall in-hospital mortality after transvascular TAVI and isolated aortic valve repair 2017 in Germany stratified to risk groups by the German Aortic Valve Score (German AV Score/AKL Score): low risk group (AKL 0- < 3%), intermediate risk group (AKL 3- < 6%), high risk group (AKL 6- < 10%) and very high risk group (AKL ≥ 10%).

Indexed as

Hospital MortalityAgedAged, 80 and overAortic Valve StenosisFemaleGermanyHumansMaleMiddle AgedPostoperative ComplicationsRisk FactorsTranscatheter Aortic Valve ReplacementAKL scoreAortic valve replacementMortalityOutcomeSurgeryTAVI

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.